One-glance verdict
Fair value unavailable
Not enough cash-flow history to value this one with our method.
Fundamentals snapshot
CHUC · OQB · Consumer Defensive · Tobacco
Current price
$0.11
52-week range
$0.01 - $0.37
Market cap
$30.86M
One-glance verdict
Not enough cash-flow history to value this one with our method.
Balance sheet
Net debt $2.14M. Interest coverage shows how many times profit covers the interest bill.
What stands out
What this company does
Charlie's Holdings, Inc. sells e-cigarette products, including those with and without nicotine, like the Pacha and PACHAMAMA brands. Their main income comes from selling these products to shops and online, and it matters because their profit depends on how many people choose their vapor products over other options.
Charlie's Holdings, through its subsidiary Charlie's Chalk Dust, LLC, develops, markets, and distributes premium vapor products. These products are designed for adult smokers looking for alternatives to traditional cigarettes. The company's offerings include both nicotine-based and non-nicotine vapor products, such as e-liquids and disposable devices. These products are sold globally through a network of distributors, specialty retailers, and online resellers.
The SBX brand represents Charlie's Holdings' line of non-nicotine alternative alkaloid products. These products are designed for adult consumers who may be looking for the taste and sensation of traditional flavored nicotine products but without the nicotine. The SBX line has been a significant driver of revenue growth for the company and has helped expand its distribution, particularly within the convenience store channel in the United States. This segment is a key focus for the company's strategy, aiming to capture market share with these alternative offerings.
The Pacha and Pachamama brands encompass Charlie's Holdings' nicotine-based disposable products and e-liquid offerings. These products are formulated with nicotine and are targeted at adult smokers seeking a satisfying vaping experience. The company has actively pursued Premarket Tobacco Product Applications (PMTAs) for a large portfolio of these products, which are essential for regulatory compliance in the vapor industry. Strategic partnerships involving the sale of PMTA assets have also been a source of income and value realization for this segment.
Metatine is another brand under which Charlie's Holdings offers alternative alkaloid products. Similar to SBX, these products focus on providing a non-nicotine alternative for adult consumers. While specific details on the size of this segment are not as prominent as SBX, it represents part of the company's broader strategy to offer a range of non-combustible and alternative nicotine-related products.
Charlie's Holdings is strategically focusing on several key areas for future growth and value creation. A major priority is the development and commercialization of age-gating technology for its disposable vape products, aiming to enhance compliance and potentially unlock significant licensing revenue through partnerships. The company is also working to monetize its extensive portfolio of Premarket Tobacco Product Applications (PMTAs), which are crucial for regulatory approval. Furthermore, Charlie's is expanding its domestic manufacturing capabilities to reduce costs and meet evolving state-level compliance requirements, while also streamlining its business by discontinuing certain product lines to focus on core growth areas and facilitate a potential uplisting to a national securities exchange.
Price history
Earnings history
Click any quarter to read the call summary and what the numbers say.
Is it cheap or expensive?
We couldn't calculate a fair value right now.
Is it drowning in debt?
Net debt $2.1M. Interest coverage -3.1x.
Charlie's Holdings, Inc.'s profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here and 5 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.
Total debt $2.66M Interest coverage -3.13x This is the baseline the peer rows are being compared against.
Total debt $4.14M Interest coverage -87.11x Neither company has much profit cushion over interest right now.
Total debt $391.69K Interest coverage -7.86x Neither company has much profit cushion over interest right now.
Total debt $1.75M Interest coverage -7.85x Neither company has much profit cushion over interest right now.
Total debt $0.00 Interest coverage -754.22x Neither company has much profit cushion over interest right now.
Total debt $0.00 Interest coverage -132.24x Neither company has much profit cushion over interest right now.
What you should know
The numbers
Tap any ? icon to learn what it means.
Valuation
Profitability
Health
Growth
Cash flow
Dividend
Metric explainer
Debt comparison
What you should know